Impact of anti-HER2 therapy alone and in association with weekly paclitaxel on the ovarian reserve of young women with HER2-positive early breast cancer: Biomarker analysis of the NeoALTTO trial.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Matteo Lambertini, Marcello Ceppi, Richard Anderson, David A. Cameron, Sarra El-Abed, Yingbo Wang, Christophe Lecocq, Paolo Nuciforo, Rebecca Rolyance, Lajos Pusztai, Joohyuk Sohn, Luca Arecco, Lucia Del Mastro, Ann H. Partridge, Cristina Saura, Michael Untch, Martine J. Piccart-Gebhart, Serena Di Cosimo, Evandro de Azambuja, Isabelle Demeestere
Institutions: Ospedale Policlinico San Martino, MRC Centre for Reproductive Health, University of Edinburgh, Institute of Genetics and Cancer, Breast International Group, Novartis (Switzerland), Vall d'Hebron Institute of Oncology, Yale University, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, University of Genoa, Dana-Farber Cancer Institute, Helios Hospital Berlin-Buch, Université Libre de Bruxelles, Institut Jules Bordet, Fondazione IRCCS Istituto Nazionale dei Tumori
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281779039